SPECTRUM PHARMACEUTICALS INC (SPPI)       0.4614  0 (-0.82%)

0.4614  0 (-0.82%)

US84763A1088 - Common Stock - After market: 0.4698 +0.01 (+1.82%)

SPECTRUM PHARMACEUTICALS INC0.4614

NASDAQ:SPPI (12/6/2022, 7:04:34 PM)0 (-0.82%)

After market: 0.4698 +0.01 (+1.82%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 11-10 2022-11-10/amc Earnings (Next) 03-15 2023-03-15
Ins Owners 1.75% Inst Owners 25.99%
Market Cap 93.76M Shares 203.21M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 80
IPO 09-26 1996-09-26

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

SPPI Daily chart

Company Profile

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of a pipeline of novel and targeted oncology therapies. The company is headquartered in Henderson, Nevada and currently employs 163 full-time employees. The firm is focused on acquiring, developing, and commercializing targeted oncology therapies. The firm's product portfolio consists of in-development drug products for the treatment of cancer patients. The firm's pipeline products include Eflapegrastim and Poziotinib. The Eflapegrastim is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib is a, pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. The Eflapegrastim employs a LAPSCOVERY technology to enhance the duration of therapeutic effects and reduce the frequency of administration.

Company Info

SPECTRUM PHARMACEUTICALS INC

11500 S Eastern Ave Ste 240

Henderson NEVADA 89052

P: 17028356300.0

CEO: Joseph W. Turgeon

Employees: 163

Website: https://www.sppirx.com/

SPPI Twits

Here you can normally see the latest stock twits on SPPI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example